Table 2.
Study outcomes.
| GROUP 1 EUS-Guided Liver Biopsy (54 pts) |
GROUP 2 Percutaneous Liver Biopsy (62 pts) |
p Value | |
|---|---|---|---|
| Total length of specimen (mm) | 0.02 | ||
| median (IQR) | 18.5 (10.1–22.4) | 27.4 (21–29) | |
| No. of complete portal tracts | 0.09 | ||
| Median (IQR) | 18.5 (10–23.2) | 21 (11–24) | |
| Diagnostic adequacy | 0.74 | ||
| 51 (94.4%) | 62 (100%) | ||
| Diagnostic accuracy * | 0.82 | ||
| 24 (88.8%) | 31 (100%) | ||
| Final diagnosis | 0.74 | ||
| Hepatocellular carcinoma | 12 | 16 | |
| Liver metastasis | 14 | 10 | |
| Chronic hepatitis | 17 | 24 | |
| NASH | 4 | 4 | |
| Normal liver | 7 | 8 | |
| Procedural duration (mins) | <0.001 | ||
| median (min, max) | 7 (5–11) | 1 (1–3) | |
| Procedure-related severe adverse events | 1.0 | ||
| 0 (0%) | 0 (0%) |
Values are expressed as number (percentage) or median (interquartile ranges) where specified; * Patients with focal lesions; Abbreviations: EUS, Endoscopic Ultrasound; IQR, Interquartile Range. The bold indicates results with statistical significance.